³Ô¹ÏÍøÕ¾

Latest lung cancer News | Page 3

Construction blitz to target falls from height and asbestos  
Tagrisso plus chemotherapy reduced the risk of disease progression in the brain by 42% in patients with EGFR-mutated advanced lung cancer and…
Important workers compensation reforms supporting fire-fighters pass Parliament
COVID-19 first infectious disease in top 5 causes of death since 1970
New target to beat cancer drug resistance
Progressing nation-leading reforms for our firefighters
Imugene secures new patent in Japan for PD1-Vaxx clinical drug candidate
Enhertu demonstrated strong and durable tumour responses in previously treated HER2-mutant advanced lung cancer in DESTINY-Lung02 Phase II trial
Datopotamab deruxtecan plus Imfinzi showed promising clinical activity in the first-line advanced non-small cell lung cancer setting in TROPION-Lung04 Phase Ib trial
Leading the way in health and safety for Tasmania’s fire-fighters
Action still required to eliminate the harm caused by engineered stone
AstraZeneca data at WCLC advance ambition to have an AstraZeneca medicine for more than half of all patients treated for lung cancer by 2030
Immutep receives positive scientific advice from the European Medicines Agency
A novel strategy to suppress triple negative breast cancer growth
Greens introduce bill to expand presumptive cancer scheme for Victorian firefighters
Surviving lung cancer is just beginning
Australians living longer but dementia and Alzheimer’s a greater risk
$1.1 million for breakthrough lung disease scanner
Breakthrough lung disease scanner
Keep your lungs strong and healthy this winter with Lung Foundation Australia
Datopotamab deruxtecan met dual primary endpoint of progression-free survival in patients with advanced non-small cell lung cancer in TROPION-Lung01 Phase III trial
First method to assess exposure to common sleep disorder
First method to access exposure to common sleep disorder
Donation allows scientists to explore asbestos treatments
Engineered stone may break my bones, but its dust will hurt workers’ lung
Firefighter cancer scheme would be expanded under Greens’ bill
Datopotamab deruxtecan combinations showed encouraging tumour responses in patients with advanced non-small cell lung cancer in TROPION-Lung02 Phase Ib trial
Tagrisso achieved unprecedented survival in early-stage EGFR-mutated lung cancer, with 88% of patients alive at five years in ADAURA Phase III trial
AstraZeneca will highlight momentum of practice-changing cancer medicines across its robust pipeline at ASCO 2023
Remagine Art Prize 2023 winner announced
Positive results for Immutep’s cancer candidate in combination with MSD’s Keytruda
New treatment promises to increase lung cancer survival
Rural communities continue to miss out on healthcare services amid modest Budget measures and economic surplus
Bold vaping reforms breath of fresh air
Funding to improve cancer outcomes for Aboriginal and Torres Strait Islander peoples
Cancer Council welcomes landmark national lung cancer screening
Australian Government announces over $500 million to improve cancer outcomes for Australians
Q1 2023 results
Calls intensify for ban on lethal engineered stone
Urgent action needed to safeguard workers from engineered stone
AstraZeneca advances its pipeline and highlights progress in immuno-oncology, ADCs, cell therapy and epigenetics at AACR
Leading way in care for our firefighters
Grant to fund study of prostate cancer evolution
Grant to fund prostate cancer evolution
Radiopharm Theranostics and GenesisCare partner on development of radiopharmaceutical
Lung cancer and mesothelioma research receives funding boost
Lung cancer and mesothelioma research funding receives $480,000 boost
Court hits demolition company with $85,000 penalty